Sun Pharmaceutical Industries is voluntarily recalling 3,263 bottles of Levetiracetam, extended release tablets, an anti epileptic drug, in the US market. Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing dissolution specifications. The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol.
It has been classified as a 'Class-II recall' which FDA defined as 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
